Company intelligence / Profile preview
BIOIO
Not specified., Not specified., Not specified in public sources.bioio.tech ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
BIOIO develops pharmaceutical therapies for cancer with the potential for use as medications. No detailed clinical results are publicly available.[5]
- Therapeutic areas
- Oncology
- Modalities
- Small molecules (inferred from "pharmaceutical therapies" and typical cancer drug development)[5]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Not publicly disclosed.
Beyond the preview
Go deeper on BIOIO.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BIOIO.